Human medicines European public assessment report (EPAR): Aldara, imiquimod, Condylomata Acuminata,Keratosis,Keratosis, Actinic,Carcinoma, Basal Cell, Date of authorisation: 18/09/1998, Revision: 25, Status: Authorised

Case Medical Research ◽

10.31525/cmr-908f24 ◽

2019 ◽

Author(s):

Keyword(s):

Condylomata Acuminata ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Aldara, imiquimod, Condylomata Acuminata,Keratosis,Keratosis, Actinic,Carcinoma, Basal Cell, Date of authorisation: 18/09/1998, Revision: 25, Status: Authorised

Case Medical Research ◽

10.31525/cmr-91357f ◽

2019 ◽

Author(s):

Keyword(s):

Condylomata Acuminata ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Odomzo, sonidegib, Carcinoma, Basal Cell, Date of authorisation: 14/08/2015, Revision: 6, Status: Authorised

Case Medical Research ◽

10.31525/cmr-6a72a1 ◽

2018 ◽

Author(s):

Keyword(s):

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Odomzo, sonidegib, Carcinoma, Basal Cell, Date of authorisation: 14/08/2015, Revision: 7, Status: Authorised

Case Medical Research ◽

10.31525/cmr-6ac6f6 ◽

2019 ◽

Author(s):

Keyword(s):

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Gardasil, human papillomavirus vaccine [types 6, 11, 16, 18] (recombinant, adsorbed), Papillomavirus Infections,Uterine Cervical Dysplasia,Condylomata Acuminata,Immunization, Date of authorisation: 20/09/2006, Revision: 39, Status: Authorised

Case Medical Research ◽

10.31525/cmr-117a8d9 ◽

2019 ◽

Author(s):

Keyword(s):

Human Papillomavirus ◽

Cervical Dysplasia ◽

Condylomata Acuminata ◽

Human Papillomavirus Vaccine ◽

Papillomavirus Infections ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report ◽

Papillomavirus Vaccine ◽

Uterine Cervical Dysplasia

Download Full-text

Human medicines European public assessment report (EPAR): Gardasil, human papillomavirus vaccine [types 6, 11, 16, 18] (recombinant, adsorbed), Papillomavirus Infections,Uterine Cervical Dysplasia,Condylomata Acuminata,Immunization, Date of authorisation: 20/09/2006, Revision: 41, Status: Authorised

Case Medical Research ◽

10.31525/cmr-1177172 ◽

2019 ◽

Author(s):

Keyword(s):

Human Papillomavirus ◽

Cervical Dysplasia ◽

Condylomata Acuminata ◽

Human Papillomavirus Vaccine ◽

Papillomavirus Infections ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report ◽

Papillomavirus Vaccine ◽

Uterine Cervical Dysplasia

Download Full-text

Human medicines European public assessment report (EPAR): Silgard, human papillomavirus vaccine [types 6, 11, 16, 18] (recombinant, adsorbed), Papillomavirus Infections,Uterine Cervical Dysplasia,Condylomata Acuminata,Immunization, Date of authorisation: 19/09/2006, Revision: 33, Status: Withdrawn

Case Medical Research ◽

10.31525/cmr-f23399 ◽

2019 ◽

Author(s):

Keyword(s):

Human Papillomavirus ◽

Cervical Dysplasia ◽

Condylomata Acuminata ◽

Human Papillomavirus Vaccine ◽

Papillomavirus Infections ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report ◽

Papillomavirus Vaccine ◽

Uterine Cervical Dysplasia

Download Full-text

Human medicines European public assessment report (EPAR): Gardasil 9, human papillomavirus 9-valent vaccine (recombinant, adsorbed), Condylomata Acuminata,Papillomavirus Infections,Immunization,Uterine Cervical Dysplasia, Date of authorisation: 09/06/2015, Revision: 10, Status: Authorised

Case Medical Research ◽

10.31525/cmr-d7cc26 ◽

2019 ◽

Author(s):

Keyword(s):

Human Papillomavirus ◽

Cervical Dysplasia ◽

Condylomata Acuminata ◽

Papillomavirus Infections ◽

Vaccine Recombinant ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report ◽

Uterine Cervical Dysplasia

Download Full-text

Human medicines European public assessment report (EPAR): Silgard, human papillomavirus vaccine [types 6, 11, 16, 18] (recombinant, adsorbed), Papillomavirus Infections,Uterine Cervical Dysplasia,Condylomata Acuminata,Immunization, Date of authorisation: 19/09/2006, Revision: 33, Status: Withdrawn

Case Medical Research ◽

10.31525/cmr-f1e556 ◽

2019 ◽

Author(s):

Keyword(s):

Human Papillomavirus ◽

Cervical Dysplasia ◽

Condylomata Acuminata ◽

Human Papillomavirus Vaccine ◽

Papillomavirus Infections ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report ◽

Papillomavirus Vaccine ◽

Uterine Cervical Dysplasia

Download Full-text

Human medicines European public assessment report (EPAR): Erivedge, vismodegib, Carcinoma, Basal Cell, Date of authorisation: 12/07/2013, Date of refusal: 26/04/2013, Revision: 11, Status: Authorised

Case Medical Research ◽

10.31525/cmr-b1a4be ◽

2019 ◽

Author(s):

Keyword(s):

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Ameluz, 5-aminolevulinic acid hydrochloride, Keratosis, Actinic,Carcinoma, Basal Cell, Date of authorisation: 13/12/2011, Revision: 13, Status: Authorised

Case Medical Research ◽

10.31525/cmr-b32205 ◽

2019 ◽

Author(s):

Keyword(s):

Aminolevulinic Acid ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report ◽

Acid Hydrochloride

Download Full-text